Status:

ACTIVE_NOT_RECRUITING

Dose Reduction of IL17 and IL23 Inhibitors in Psoriasis

Lead Sponsor:

Radboud University Medical Center

Collaborating Sponsors:

ZonMw: The Netherlands Organisation for Health Research and Development

Belgium Health Care Knowledge Centre

Conditions:

Psoriasis

Psoriasis Vulgaris

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The main objective of this study is to investigate whether controlled dose reduction of IL17 or IL23 inhibiting biologics is not inferior compared to usual care in psoriasis patients. Therefore, a pra...

Detailed Description

Rationale: Biologics are very effective treatments for psoriasis. Research indicated that the dose of TNFα-blocking biologics can be reduced in a proportion of patients. Safety profiles can improve an...

Eligibility Criteria

Inclusion

  • Plaque psoriasis (primarily)
  • Treatment for at least 6 months with IL23 or IL17 inhibitor in a normal dose (dose advised by the label)
  • PASI≤ 5 at inclusion and in previous 6 months (if no PASI scores are available, it should be clear from the patient record that psoriasis was clear/almost clear in previous 6 months).
  • DLQI ≤ 5 at inclusion

Exclusion

  • Another indication than plaque psoriasis as the main indication for biologic use (e.g. patient receives biologic for rheumatoid arthritis as the main indication).
  • Concomitant use of systemic immunosuppressants other than methotrexate or acitretin (e.g. prednisone, cyclosporine etc).
  • Severe comorbidities with short life-expectancy (e.g. metastasized tumor).
  • Presumed inability to follow the study protocol.

Key Trial Info

Start Date :

August 20 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2025

Estimated Enrollment :

244 Patients enrolled

Trial Details

Trial ID

NCT04340076

Start Date

August 20 2020

End Date

December 1 2025

Last Update

September 11 2025

Active Locations (19)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (19 locations)

1

ULB Erasme

Brussels, Belgium

2

Ghent University Hospital

Ghent, Belgium, 9000

3

AZ Maria Middelares

Ghent, Belgium

4

AZ St Lucas

Ghent, Belgium